Cargando…
A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell prolife...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680388/ https://www.ncbi.nlm.nih.gov/pubmed/23776620 http://dx.doi.org/10.1371/journal.pone.0066131 |
_version_ | 1782273112512921600 |
---|---|
author | Aly, Haytham Rohatgi, Nidhi Marshall, Connie A. Grossenheider, Tiffani C. Miyoshi, Hiroyuki Stappenbeck, Thaddeus S. Matkovich, Scot J. McDaniel, Michael L. |
author_facet | Aly, Haytham Rohatgi, Nidhi Marshall, Connie A. Grossenheider, Tiffani C. Miyoshi, Hiroyuki Stappenbeck, Thaddeus S. Matkovich, Scot J. McDaniel, Michael L. |
author_sort | Aly, Haytham |
collection | PubMed |
description | Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype. |
format | Online Article Text |
id | pubmed-3680388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36803882013-06-17 A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype Aly, Haytham Rohatgi, Nidhi Marshall, Connie A. Grossenheider, Tiffani C. Miyoshi, Hiroyuki Stappenbeck, Thaddeus S. Matkovich, Scot J. McDaniel, Michael L. PLoS One Research Article Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype. Public Library of Science 2013-06-12 /pmc/articles/PMC3680388/ /pubmed/23776620 http://dx.doi.org/10.1371/journal.pone.0066131 Text en © 2013 Aly et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Aly, Haytham Rohatgi, Nidhi Marshall, Connie A. Grossenheider, Tiffani C. Miyoshi, Hiroyuki Stappenbeck, Thaddeus S. Matkovich, Scot J. McDaniel, Michael L. A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title | A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title_full | A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title_fullStr | A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title_full_unstemmed | A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title_short | A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype |
title_sort | novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680388/ https://www.ncbi.nlm.nih.gov/pubmed/23776620 http://dx.doi.org/10.1371/journal.pone.0066131 |
work_keys_str_mv | AT alyhaytham anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT rohatginidhi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT marshallconniea anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT grossenheidertiffanic anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT miyoshihiroyuki anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT stappenbeckthaddeuss anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT matkovichscotj anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT mcdanielmichaell anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT alyhaytham novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT rohatginidhi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT marshallconniea novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT grossenheidertiffanic novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT miyoshihiroyuki novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT stappenbeckthaddeuss novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT matkovichscotj novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype AT mcdanielmichaell novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype |